Quick Answer
Microbot Medical Inc. reported Cash And Cash Equivalents At Carrying Value of $3.91 million for the year ending 2025.
- Microbot Medical Inc. showed an increase of +25.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Microbot Medical Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $9.45 million | Q2 2012: $7.20 million | Q3 2012: $15.71 million | Q1 2013: $7.23 million | Q2 2013: $22.75 million | Q3 2013: $20.96 million | Q1 2014: $26.46 million | Q2 2014: $17.85 million | Q3 2014: $32.21 million | Q1 2015: $14.15 million | Q2 2015: $29.93 million | Q3 2015: $21.19 million | Q1 2016: $144.0 thousand | Q2 2016: $841.0 thousand | Q3 2016: $574.0 thousand | Q1 2017: $5.00 million | Q2 2017: $13.08 million | Q3 2017: $11.73 million | Q1 2018: $9.46 million | Q2 2018: $8.02 million | Q3 2018: $6.67 million | Q1 2019: $5.36 million | Q2 2019: $4.88 million | Q3 2019: $3.55 million | Q1 2020: $29.59 million | Q2 2020: $28.23 million | Q3 2020: $26.53 million | Q1 2021: $17.92 million | Q2 2021: $15.62 million | Q3 2021: $13.43 million | Q1 2022: $10.47 million | Q2 2022: $7.29 million | Q3 2022: $4.33 million | Q1 2023: $2.15 million | Q2 2023: $5.72 million | Q3 2023: $1.34 million | Q1 2024: $1.16 million | Q2 2024: $2.47 million | Q3 2024: $479.0 thousand | Q1 2025: $3.22 million | Q2 2025: $4.08 million | Q3 2025: $6.70 million.
- Over the full 18 years of available data (2008 to 2025), Microbot Medical Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 87.0%.
- Historical annual values: Fiscal year 2025: $3.91 million | Fiscal year 2024: $3.11 million | Fiscal year 2023: $2.47 million | Fiscal year 2022: $2.44 million | Fiscal year 2021: $13.49 million | Fiscal year 2020: $19.65 million | Fiscal year 2019: $28.77 million | Fiscal year 2018: $5.24 million | Fiscal year 2017: $10.79 million | Fiscal year 2016: $2.71 million | Fiscal year 2015: $437.0 thousand | Fiscal year 2014: $791.0 thousand | Fiscal year 2013: $30.59 million | Fiscal year 2012: $8.47 million | Fiscal year 2011: $13.31 million | Fiscal year 2010: $19.71 million | Fiscal year 2009: $38.62 million | Fiscal year 2008: $30.04 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: